Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
06:05pm, Tuesday, 10'th May 2022 Zacks Investment Research
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
03:48pm, Tuesday, 10'th May 2022
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
BBH ETF: Buy This ETF At Discounted Price And Hold It For Long Term
03:34pm, Thursday, 28'th Apr 2022
BBH's price multiples indicate an undervaluation and its major holdings have started recording significant price growth. BBH has strong fundamentals and has performed well enough in the medium and lon
Positioning for Biotech Bounceback
11:17am, Friday, 01'st Apr 2022
Biotechnology stocks and exchange traded funds have frustrated investors for over a year now, but some analysts and experts believe that this gloomy trend will end soon. Investors willing to take that
Moderna ETFs Rallying on COVID-19 Vaccine Booster Shot Update
06:42pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Moderna has been rallying on the latest positive booster shot-related update.
Make Biotech Cash Considerations With SBIO
08:59pm, Monday, 28'th Mar 2022
In financial markets, it's often said that cash is king. That's something to remember when it comes to the biotechnology universe due to the cost-intensive nature of developing new drugs and therapies
Should You Invest in the VanEck Biotech ETF (BBH)?
10:20am, Tuesday, 15'th Mar 2022 Zacks Investment Research
Sector ETF report for BBH
Should You Invest in the VanEck Biotech ETF (BBH)?
07:32am, Tuesday, 15'th Mar 2022
Sector ETF report for BBH
Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns
04:30pm, Monday, 14'th Mar 2022
Biotechnology sector-related exchange traded funds gained on Monday, with Moderna Inc. (NasdaqGS: MRN) sitting among the top performers in the S&P 500, on renewed COVID-19 concerns as China implements
SBIO Is a Good Place to Be for Biotech Innovation
04:22pm, Monday, 28'th Feb 2022
While biotechnology stocks and exchange traded funds continue frustrating market participants in the early innings of 2022, investors should not lose sight of the fact this corner of the healthcare se
XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector
03:11am, Tuesday, 15'th Feb 2022
The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech.
How Are Biotech ETFs Reacting to These Q4 Earnings Releases?
10:00pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
How Are Biotech ETFs Reacting to These Q4 Earnings Releases?
06:25pm, Thursday, 10'th Feb 2022
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
Biotech ETFs Muddled Despite Amgen Strength
07:20pm, Tuesday, 08'th Feb 2022
Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share b
Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit
01:00pm, Tuesday, 11'th Jan 2022 Zacks Investment Research
Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.
